The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVersarien Regulatory News (VRS)

Share Price Information for Versarien (VRS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.1005
Bid: 0.10
Ask: 0.1045
Change: 0.00 (0.00%)
Spread: 0.0045 (4.50%)
Open: 0.1005
High: 0.00
Low: 0.00
Prev. Close: 0.1005
VRS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Placing to raise £650,000

14 Jul 2023 07:00

RNS Number : 9962F
Versarien PLC
14 July 2023
 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF THE MARKET ABUSE REGULATION (EU) 596/2014 (AS AMENDED) AS IT FORMS PART OF THE DOMESTIC LAW OF THE UNITED KINGDOM BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018 (AS AMENDED). UPON PUBLICATION OF THIS ANNOUNCMENT, THIS INSIDE INFORMATION IS NOW CONSIDERED TO BE IN THE PUBLIC DOMAIN.

 

14 July 2023

 

Versarien plc

 

("Versarien" or the "Company")

 

Placing to raise £650,000

 

Versarien plc (AIM: VRS), the advanced materials engineering group, announces it has raised £650,000 (before expenses) by way of a placing (the "Placing") of 65,000,000 new ordinary shares in the capital of the Company ("Placing Shares") at a price of 1.0 pence per share (the "Placing Price").

 

Highlights

 

· Versarien has raised £650,000, before expenses, through placing of 65,000,000 new ordinary shares in the capital of the Company at a price of 1.0 pence per share

· The net proceeds of the Placing will be used for working capital purposes and as bridge finance to extend the Company's cash runway ahead of any funds received from asset sales

· The issue of the Placing Shares is within existing authorities granted by shareholders at the general meeting of the Company held in July 2023 and therefore no shareholder approval is required for the Placing

· Company directors, Chris Leigh and Stephen Hodge, participated in the Placing

 

 

Use of Proceeds and Turnaround Strategy

 

The net proceeds of the Placing will be used for working capital purposes and as bridge finance to extend the Company's cash runway ahead of any funds received from asset sales.

 

As previously announced, the Company is pursuing a disposal of assets, including its mature businesses and the intellectual property and plant acquired from Hanwha Aerospace in 2020, and a number of interested parties are reviewing information in the data rooms. The timing of any asset sales and the quantum of the funds that may be received is uncertain.

 

Chris Leigh, Chief Financial Officer of Versarien, commented:

 

"Following the passing of the resolutions at the general meeting held earlier this month, the Board has decided that it would be prudent to raise further finance to assist in bridging to the proposed asset sales. We look forward to updating shareholders on continuing progress with the turnaround strategy in the coming months."

 

Director Participation

 

The following directors of Versarien participated in the Placing:

 

Director

Number of Placing Shares subscribed for

Total Ordinary Shares following the Placing

Total interest in the enlarged share capital

Chris Leigh, Chief Financial Officer

1,000,000

1,315,000

0.40%

Stephen Hodge, Chief Technology Officer

1,000,000

1,046,774

0.32%

 

Related Party Transaction

 

The Placing participation from Chris Leigh and Stephen Hodge is considered a related-party transaction for the purposes of Rule 13 of the AIM Rules for Companies. The directors (other than Chris Leigh and Stephen Hodge) consider, having consulted with SP Angel Corporate Finance LLP, the Company's nominated adviser, that the participation by Chris Leigh and Stephen Hodge in the Placing is fair and reasonable in so far as Versarien's shareholders are concerned.

 

Admission and Total Voting Rights

 

Application will be made for admission of the Placing Shares to be admitted to trading on AIM ("Admission") on or around 20 July 2023. The Placing Shares will rank pari passu in all respects with the Company's existing ordinary shares. Following Admission, the total number of ordinary shares in the Company in issue will be 330,779,690. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company under the FCA's Disclosure and Transparency Rules.

 

For further information please contact:

 

Versarien

Chris Leigh, Chief Financial Officer

Stephen Hodge, Chief Technology Officer

c/o IFC

SP Angel Corporate Finance (Nominated Adviser and Broker)

Matthew Johnson, Adam Cowl

+44 (0)20 3470 0470

 

 

IFC Advisory Limited (Financial PR and Investor Relations)

Tim Metcalfe, Zach Cohen

+44 (0) 20 3934 6630

 

About Versarien:

 

The strategy of Versarien plc (AIM:VRS) is to be a development led advanced materials company focussed on specific sectors that will lead to a light manufacturing and licensing model.

 

For further information please see: http://www.versarien.com

 

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them:

 

1.

Details of the person discharging managerial responsibilities/person closely associated

(1)

Full name of person Dealing

1. Chris Leigh

 2. Stephen Hodge

2.

Reason for notification

(2)

Position/status

1. Chief Financial Officer

2. Chief Technology Officer

(3)

Initial notification/ Amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

(4)

Name of entity

Versarien plc

(5)

LEI

213800D6NZED7V8W2Z34

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

(6)

Description of the financial instrument, type of instrument

Ordinary shares of 1 pence each

(7)

Identification code

GB00B8YZTJ80

(8)

Nature of the transaction

Participation in Placing

(9)

Price(s) and volume(s)

Share Prices(s)

Share Volume(s)

1. 1 pence

1,000,000

2. 1 pence

1,000,000

(10)

Aggregated information:

- Aggregated volume

- Price

Single transaction as in 4(d) above

Share Prices(s)

Share Volume(s)

1. 1 pence

1,000,000

2. 1 pence

1,000,000

(11)

Date of transaction

14 July 2023

(12)

Place of transaction

Outside a trading venue

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IOEGPUAWMUPWPUW
Date   Source Headline
12th Feb 20204:35 pmRNSPrice Monitoring Extension
11th Feb 20204:40 pmRNSSecond Price Monitoring Extn
11th Feb 20204:36 pmRNSPrice Monitoring Extension
11th Feb 20202:05 pmRNSSecond Price Monitoring Extn
11th Feb 20202:00 pmRNSPrice Monitoring Extension
11th Feb 202011:05 amRNSSecond Price Monitoring Extn
11th Feb 202011:00 amRNSPrice Monitoring Extension
10th Feb 20207:00 amRNSResponse to share price movement
21st Jan 20207:00 amRNSUS Update
18th Dec 20197:00 amRNSAirbus Graphene Flagship Project
12th Dec 20197:00 amRNSInterim Results
27th Nov 20197:00 amRNSNotice of Results
27th Nov 20197:00 amRNSTextile Commercial Partnership Agreement
1st Nov 20192:05 pmRNSSecond Price Monitoring Extn
1st Nov 20192:00 pmRNSPrice Monitoring Extension
9th Oct 20197:00 amRNSRefractory Materials Collaboration
24th Sep 20191:38 pmRNSResult of AGM
24th Sep 20197:00 amRNSAGM Statement
20th Sep 201911:47 amRNSSecond Price Monitoring Extn
20th Sep 201911:46 amRNSPrice Monitoring Extension
19th Sep 20192:05 pmRNSSecond Price Monitoring Extn
19th Sep 20192:00 pmRNSPrice Monitoring Extension
22nd Aug 20199:35 amRNSAppointment of Joint Broker
21st Aug 20191:35 pmRNSNotice of AGM and Posting of Annual Report
9th Aug 20197:54 amRNSChina Update and Clarification
6th Aug 20197:00 amRNSAnnual General Meeting
26th Jul 20197:00 amRNSLOI with Global Apparel Manufacturer
24th Jul 20197:00 amRNSTransport Infrastructure Technology Preview Event
17th Jul 20197:00 amRNSPreliminary Results
16th Jul 20197:00 amRNSInvestor Event
15th Jul 20198:00 amRNSReceipt of Graphene REACH Registration
11th Jul 201910:30 amRNSNotice of Results
8th Jul 20197:00 amRNSJapanese Graphene Order
1st Jul 20197:00 amRNSAppointment of Director
28th Jun 20197:00 amRNSUS Graphene Order
27th Jun 20192:33 pmRNSAppointment of New Head of US Operations
19th Jun 20192:16 pmRNSResponse to Commentary Regarding US Employee
29th May 20193:00 pmRNSCollaboration Agreement with BP Polymers
9th May 20197:00 amRNSUSA Update
15th Apr 20196:03 pmRNSDirector/PDMR Shareholding
15th Apr 20197:00 amRNSTerm Sheet with Beijing Institute of Graphene Tech
4th Apr 20198:29 amRNSUS Appointment Update
1st Apr 20197:00 amRNSCompletion of Verified Graphene Producer Programme
29th Mar 20197:00 amRNSExtension of DIT Secondment
21st Mar 20197:00 amRNSUSA Update
14th Mar 20197:00 amRNSLOI with Tunghsu Optoelectronic
7th Mar 201911:42 amRNSFurther Chinese Aerospace Collaboration
5th Mar 20199:00 amRNSPrice Monitoring Extension
1st Mar 20192:05 pmRNSSecond Price Monitoring Extn
1st Mar 20192:00 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.